Background stories of how others approached and experienced their European Horizon funding trajectory.
The UNCHAIN project, ‘urban logistics and planning: anticipating urban freight generation and demand including digitalisation of urban freight’ obtained funding from the Horizon Europe’s Mobility Cluster. The project focuses on breaking down data silos and promoting public-private data exchange across a unified European mobility data space, enabling more informed decisions and greater efficiency. The City of Mechelen is a partner in the project and takes on the role of ‘follower city’: it will work alongside the primary demonstration sites (in Madrid, Berlin and Florence) to maximize the geographical coverage and replicability of solutions across Europe. Mechelen aims to test 2 concrete solutions in the UNCHAIN project, with the aim to help addressing its current and future challenges in urban freight distribution.
Read the full article for detailsThe METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.